Robert O. Dillman
Professor/Chief Medical Officer
AIVITA Biomedical, Inc
Robert O. Dillman, MD, is Chief Medical Officer for AIVITA Biomedical, Inc, Irvine, CA, and Clinical Professor of Medicine, University of California, Irvine. He earned degrees from Stanford and Baylor College of Medicine, and trained in internal medicine at Baylor, and hematology and oncology at University of California San Diego. His career has focused on clinical research in cancer immunotherapy with monoclonal antibodies and cellular immunotherapies. For over 20 years he directed a bench-to-bedside translational cell biology laboratory specializing in patient-specific cell-based therapies. He has over 300 publications and is a past-president of the Society for Immunotherapy of Cancer (SITC).
Translational cell biology